Hiromitsu Kumada

Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma

Kenji Ikeda, Satoshi Saitoh, Akihito Tsubota et al. · Cancer · 1993 · 253 citations · Full text

Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis

Masahiro Kobayashi, Kenji Ikeda, Satoshi Saitoh et al. · Cancer · 2000 · 246 citations · Full text

Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study

Masatoshi Kudo, Zhenggang Ren, Yabing Guo et al. · The Lancet · 2025 · 161 citations

Hepatology, Non-metastatic Hepatocellular Carcinoma, Transarterial Chemoembolisation +8

Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection

Akihito Tsubota, Hiromitsu Kumada, Yasuji Arase et al. · European Journal of Gastroenterology & Hepatology · 1999 · 62 citations

Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas

Satoshi Saitoh, K Ikeda, Isao Koida et al. · Cancer · 1994 · 30 citations · Full text